FemiCore Ingredients Explained: Formula and Research

Editorial research • Last reviewed November 6, 2026 • Source citations below

FemiCore is marketed as a women’s urinary-support supplement combining botanical ingredients and probiotics. The most important buyer questions are whether the formula has been tested as a whole, whether its ingredient amounts are disclosed, and whether the checkout and refund terms are clear.

Reported Supplement Facts: what is disclosed?

A published secondary transcription reports a 350 mg herbal blend and 50 mg probiotic blend per one-capsule serving. Neither individual ingredient milligrams nor viable probiotic CFU counts are established from a manufacturer-authenticated label. Do not treat these numbers as verified until a clear rear-label photograph is obtained.

Reported blend	Total reported	Unresolved information
Herbal blend	350 mg	Individual botanical quantities and exact active doses
Probiotic blend	50 mg	CFU counts, viability at expiration, and independently authenticated strain codes

The nine reported ingredients

Mimosa pudica seed extract

Plant ingredient promoted in the blend; direct human evidence for bladder control is not established.

Cranberry extract

Some cranberry preparations have evidence for recurrent UTI prevention in selected groups. This does not demonstrate reduced bladder leakage or prove that FemiCore supplies a studied PAC dose.

Bearberry leaf (uva ursi)

Traditional urinary-use herb. Safety, kidney health, and duration of use deserve particular attention.

Berberine HCl extract

Investigated for several biological effects, but clinical proof of bladder-leakage benefits from this formula is lacking.

Lactobacillus crispatus

Species with urinary/vaginal microbiome research; trial results depend on the exact strain and administration route.

Lactobacillus acidophilus

Common probiotic species; results from other strains cannot be transferred to this product.

Lactobacillus plantarum

Studied for gut and microbiome outcomes, but FemiCore-specific urinary benefit is unproven.

Lactobacillus gasseri

Biological plausibility does not establish meaningful bladder outcomes at undisclosed CFU counts.

Lactobacillus casei

Evidence is strain-specific and cannot substitute for a finished-product clinical trial.

Why the undisclosed doses matter

A blend total cannot show how much cranberry PAC, bearberry, or berberine is present. Similarly, probiotic weight in milligrams does not state the number of living organisms. Studies on a particular strain, dose, or route cannot be extrapolated to an unverified combination.

Strain-code discrepancy to resolve

Third-party ingredient descriptions are not fully consistent on some probiotic strain identifiers. This site therefore lists the species only until the authentic Supplement Facts panel is available. Any precise strain identifiers require source-level confirmation.

What would improve formula transparency?

A readable photograph of the actual Supplement Facts panel
Per-ingredient doses and cranberry PAC amount in milligrams
Probiotic CFU count at expiration and verified strain identifiers
A batch-specific certificate of analysis, if available

Frequently Asked Questions

Are the ingredient doses disclosed?

The available secondary label descriptions do not disclose individual doses. The total blend weights do not solve this limitation.

Is cranberry clinically proven for bladder leakage?

No. Evidence about recurrent UTI prevention cannot be substituted for clinical evidence about urinary incontinence.

Do the probiotics have a verified CFU count?

No authenticated CFU disclosure was available for this assessment.

Sources and evidence notes

References are provided for research context. Sources discussing individual ingredients do not demonstrate effectiveness of the finished FemiCore formula.